Gelteq Ltd
GELS0.897USD
+0.038+4.37%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
9.61MMarket Cap
LossP/E TTM
More Details of Gelteq Ltd Company
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Gelteq Ltd Info
Ticker SymbolGELS
Company nameGelteq Ltd
IPO dateOct 29, 2024
CEOGivoni (Nathan Jacob)
Number of employees7
Security typeOrdinary Share
Fiscal year-endOct 29
AddressLevel 4
CityMELBOURNE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryAustralia
Postal code3205
Phone61390873990
Websitehttps://www.gelteq.com
Ticker SymbolGELS
IPO dateOct 29, 2024
CEOGivoni (Nathan Jacob)
Company Executives of Gelteq Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Markoff (Jeffrey)
22.79%
Golik (David)
9.45%
Givoni (Nathan Jacob)
6.13%
Crestmont Pty Ltd
6.00%
Szewach (Simon Hayden)
3.16%
Other
52.47%
Shareholders
Shareholders
Proportion
Markoff (Jeffrey)
22.79%
Golik (David)
9.45%
Givoni (Nathan Jacob)
6.13%
Crestmont Pty Ltd
6.00%
Szewach (Simon Hayden)
3.16%
Other
52.47%
Shareholder Types
Shareholders
Proportion
Individual Investor
41.53%
Corporation
6.00%
Investment Advisor
0.54%
Research Firm
0.34%
Other
51.59%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
8
105.80K
1.05%
--
2025Q3
8
105.80K
1.05%
--
2025Q2
8
105.80K
1.09%
+654.00
2025Q1
5
105.14K
0.84%
+24.19K
2024Q4
3
80.95K
0.00%
+80.95K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Markoff (Jeffrey)
2.44M
24.34%
--
--
Nov 15, 2024
Golik (David)
1.01M
10.09%
--
--
Nov 15, 2024
Givoni (Nathan Jacob)
657.09K
6.55%
--
--
Nov 15, 2024
Crestmont Pty Ltd
642.32K
6.41%
--
--
Nov 15, 2024
Szewach (Simon Hayden)
338.20K
3.37%
--
--
Nov 15, 2024
Wedbush Securities, Inc.
20.00K
0.2%
-32.25K
-61.72%
Jun 30, 2025
Virtu Americas LLC
12.24K
0.12%
+12.24K
--
Jun 30, 2025
HRT Financial LP
44.62K
0.44%
+44.62K
--
Jun 30, 2025
UBS Financial Services, Inc.
5.54K
0.06%
-17.92K
-76.39%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Gelteq Ltd?
The top five shareholders of Gelteq Ltd are:
Markoff (Jeffrey) holds 2.44M shares, accounting for 24.34% of the total shares.
Golik (David) holds 1.01M shares, accounting for 10.09% of the total shares.
Givoni (Nathan Jacob) holds 657.09K shares, accounting for 6.55% of the total shares.
Crestmont Pty Ltd holds 642.32K shares, accounting for 6.41% of the total shares.
Szewach (Simon Hayden) holds 338.20K shares, accounting for 3.37% of the total shares.
Markoff (Jeffrey) holds 2.44M shares, accounting for 24.34% of the total shares.
Golik (David) holds 1.01M shares, accounting for 10.09% of the total shares.
Givoni (Nathan Jacob) holds 657.09K shares, accounting for 6.55% of the total shares.
Crestmont Pty Ltd holds 642.32K shares, accounting for 6.41% of the total shares.
Szewach (Simon Hayden) holds 338.20K shares, accounting for 3.37% of the total shares.
What are the top three shareholder types of Gelteq Ltd?
The top three shareholder types of Gelteq Ltd are:
Markoff (Jeffrey)
Golik (David)
Givoni (Nathan Jacob)
Markoff (Jeffrey)
Golik (David)
Givoni (Nathan Jacob)
How many institutions hold shares of Gelteq Ltd (GELS)?
As of 2025Q4, 8 institutions hold shares of Gelteq Ltd, with a combined market value of approximately 105.80K, accounting for 1.05% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Gelteq Ltd?
In --, the -- business generated the highest revenue for Gelteq Ltd, amounting to -- and accounting for --% of total revenue.
